Lipid-Based Formulation of Baricitinib for the Topical Treatment of Psoriasis

• Main Authors: Roya Mohammadi-Meyabadi (Author), Mireia Mallandrich (Author), Negar Beirampour (Author), Núria Garrós (Author), Lupe Carolina Espinoza (Author), Lilian Sosa (Author), Joaquim Suñer-Carbó (Author), María José Rodríguez-Lagunas (Author), María Luisa Garduño-Ramírez (Author), Ana C. Calpena-Campmany (Author)
• Format: Book
• Published: MDPI AG, 2024-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Baricitinib, commonly used for autoimmune diseases, is typically administered orally, which can lead to systemic adverse effects. A topical formulation could potentially offer localized therapeutic effects while minimizing these side effects. Objectives: This study focuses on developing...